Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. by Gao, S, Bajrami, I, Verrill, C, Kigozi, A, Ouaret, D, Aleksic, T, Asher, R, Han, C, Allen, P, Bailey, D, Feller, S, Kashima, T, Athanasou, N, Blay, J, Schmitz, S, Machiels, J, Upile, N, Jones, T, Thalmann, G, Ashraf, S, Wilding, J, Bodmer, W, Middleton, MR, Ashworth, A, Lord, C

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer by Centenera, MM, Scott, JS, Machiels, J, Nassar, ZD, Miller, DC, Zininos, I, Dehairs, J, Burvenich, IJG, Zadra, G, Chetta, P, Bango, C, Evergren, E, Ryan, NK, Gillis, JL, Mah, CY, Tieu, T, Hanson, AR, Carelli, R, Bloch, K, Panagopoulos, V, Waelkens, E, Derua, R, Williams, ED, Evdokioou, A, Cifuentes-Rius, A, Voelcker, NH, Mills, IG, Tilley, WD, Scott, AM, Loda, M, Selth, LA, Swinnen, JV, Butler, LM